Imagine a world where a baby’s first months are threatened by something as essential as their formula. That’s the chilling reality for 23 infants across 13 states, who have been diagnosed with botulism after consuming ByHeart Whole Nutrition infant formula. This outbreak isn’t just a health crisis—it’s a wake-up call about the cracks in our food safety system. But here’s where it gets controversial: experts warn that recent federal actions may be weakening our ability to respond to such emergencies. Could budget cuts and policy shifts be putting our most vulnerable at risk? Let’s dive in.
The alarm was first raised by the Infant Botulism Treatment and Prevention Program (IBTPP) within the California Department of Public Health (CDPH). They noticed a surge in requests for BabyBIG, the only FDA-approved treatment for infant botulism, and traced a common thread: ByHeart formula. By November 8, ByHeart recalled two lots of their product, expanding the recall nationwide on November 11 at the FDA’s request. The FDA, CDC, and state partners are now investigating, but the CDC’s silence on the matter raises eyebrows. And this is the part most people miss: botulism in infants is caused by swallowing spores of Clostridium botulinum, which produce a toxin that can lead to muscle weakness, breathing difficulties, and even death if untreated.
As of November 14, all 23 affected infants, ranging from 16 to 200 days old, have been hospitalized and treated with BabyBIG. Thankfully, no deaths have been reported. But the numbers are alarming: of 84 botulism cases in U.S. infants between August 1 and November 10, 36 were linked to formula, with 15 (42%) involving ByHeart—a brand that accounts for just 1% of U.S. formula sales. That’s a red flag, according to Susan Mayne, former director of the FDA’s Center for Food Safety and Applied Nutrition. She notes that while essential teams like the FDA’s Coordinated Response and Evaluation Network worked through the federal shutdown, broader systemic issues remain.
Here’s where it gets even more troubling: recent policy changes may be undermining our defenses. This summer, the Foodborne Diseases Active Surveillance Network reduced the number of pathogens states are required to monitor from eight to just two—botulism wasn’t even on the original list. Earlier this year, the Trump administration disbanded the National Advisory Committee on Microbiological Criteria for Foods, which was set to release a critical report on microbial contamination in infant formula. Add to that the FDA’s mass layoffs in February, which included food safety scientists and inspectors, and the picture becomes clearer: our safety net is fraying.
The CDC hasn’t been spared either. Last month’s layoffs eliminated the agency’s entire Washington office, cutting off direct communication with Congress. As Sarah Sorscher of the Center for Science in the Public Interest points out, this office would have been crucial in keeping lawmakers informed during this outbreak. Without it, there’s a dangerous communication gap.
While the 2022 formula shortage won’t likely repeat due to ByHeart’s small market share, this outbreak is a stark reminder of the need for vigilance. Mayne and Sorscher agree: the federal government must prioritize preventing microbial contamination in infant formula. But here’s a thought-provoking question: Are we doing enough to balance budget constraints with public health priorities? Or are we risking our youngest lives in the process? Let’s keep the conversation going—share your thoughts below.
